Regneron

FDA Approves Sanofi SA's and Regeneron Pharmaceuticals Inc's Zaltrap for Metastatic Colorectal Cancer
Reuters
Fri, 06/6/14 - 10:08 am
FDA
Sanofi
Regneron
Zaltrap
colorectal cancer